A promising vaccine under development by Sanaria has some malaria strains running scared. The PfSPZ vaccine was shown to not only protect 64% of subjects from contracting the strain of malaria the treatment was developed from, the vaccine also protected 5 of the 6 subjects treated and exposed to a different strain. Sorry subject #6! Oh, and it does all this while affording eight months of protection at >90% efficacy, which no malaria vaccine to date has been able to do. It’s currently in Phase I, though it has been given fast track designation, so if it can survive the arduous clinical trials process it could be a very important tool in the fight to eradicate malaria.
What’s small, lightweight and portable all while being faster and less than a hundredth of the cost of the cheapest centrifuge we could find on Amazon? Meet the ‘Paperfuge.’ It’s 2 grams, can separate plasma from blood in 90 seconds, and costs a paltry 20 cents. All these specifications mean that diagnosing diseases like HIV and malaria in areas that don’t typically have access to clunky, electricity-dependent clinical equipment (see: malaria prevalent areas) is going to be so much easier. The design comes from a group of Stanford University researchers who performed a similar feat in 2012 by creating a paper microscope for 50 cents. Origami? More like ohmygoshi! (Our puns only get worse with every groan from readers.)
Mosquitoes are one of the few creatures in this world where we must ask “Was there a point to this?” While InsightCity can’t explain this insanely wrong turn in evolution, GSK, PATH, and the GAVI Vaccine Alliance are teaming up to combat the blood-sucking treachery. GSK and PATH recently committed to donate the first malaria vaccine candidate -RTS,S- towards a large-scale WHO pilot implementation program in sub-Saharan Africa, researching real-world impact of the game-changing medication. Gavi has announced a $27.5 million donation towards the operation. Sub-Saharan Africa is hit especially hard by the mosquito-transmitted illness resulting in thousands of deaths annually- especially in younger populations. If full funding can be secured by WHO, the program will begin in early 2018. Here are 33 mosquito facts. Because…why not?